Immetas Therapeutics Announces Series A Financing to Advance Research on Inflammation Pathways in Aging and Develop Therapeutics for Cancer and Inflammatory Disease

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/3iYaz3L
via IFTTT